Permeability and adsorption capacity of dialysis membranes to lipid A

International Journal of Artificial Organs

Volumn 20, Issue 3, 1997, Pages 144-152

  Weber, C ^a   Linsberger, I ^a   Rafiee Tehrani, M ^b   Falkenhagen, D ^a  

^a DANUBE UNIVERSITY KREMS   (Austria)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

endotoxins; hemodialysis; lipid A; LPS; pyrogens

Indexed keywords

DIALYSIS MEMBRANES; ESCHERICHIA COLI; HEMODIALYZERS; MICROFILTRATION;

ADSORPTION CAPACITIES; ENDOTOXIN; HAEMODIALYSIS; HAEMODIALYSIS MEMBRANES; IN-VITRO; LIPID A; LOW MOLECULAR WEIGHT; LPS; MODEL SUBSTANCE; PSEUDOMONAS AERUGINOSA;

DIALYSIS;

ENDOTOXIN; LIPID A; PYROGEN;

ADSORPTION; ARTICLE; BACTERIUM; DIALYSIS;

EID: 0030904844     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139889702000304     Document Type: Article

References (70)

1. Kidd EE. Bacterial contamination of dialysing fluid of artificial kidney. Brit Med J 1964; 1: 880-2.
2. Raij L, Shapiro FL, Michael AF. Endotoxemia in febrile reactions during hemodialysis. Kidney Int 1973; 4: 57-60.
3. Favero MS, Petersen NJ, Boyer KM, Carson LA, Bond WW. Microbial contamination of renal dialysis systems and associated health risks. Trans Am Soc Artif Internal Organs 1974; 20: 175-83.
4. Kolmos HJ. Hygienic problems in dialysis. Factors determining bacterial contamination of fluids and equipment used for haemo- and peritoneal dialysis, associated health risks, and methods of prevention. Dan Med Bull 1985; 32: 338-61.
5. Bommer J, Ritz E. Water quality - a neglected problem in hemodialysis. Nephron 1987; 46: 1-6.
6. Harding GB, Klein E, Pass T, Wright R, Million C. Endotoxin and bacterial contamination of dialysis center water and dialysate; a cross sectional survey. Int J Artif Organs 1990; 13: 39-43.
7. Klein E, Pass T, Harding GB, Wright R, Million C. Microbial and endotoxin contamination in water and dialysate in the Central United States. Artif Organs 1990; 14: 85-94.
8. Kulander L, Nisbeth U, Danielsson BG, Eriksson Ö. Occurrence of endotoxin in dialysis fluid from 39 dialysis units. J Hosp Infect 1993; 24: 29-37.
9. Bambauer R, Schauer M, Jung WK, Daum V, Vienken J. Contamination of dialysis water and dialysate. A survey of 30 centers. ASAIO J 1994; 40: 1012-6.
10. Baurmeister U, Travers M, Vienken J, et al. Dialysate contamination and back filtration may limit the use of high-flux dialysis membranes. ASAIO Trans 1989; 35: 519-22.
11. Smollich BP, Falkenhagen D, Schneidewind J, Mitzner S, Klinkmann H. Importance of endotoxins in high-flux dialysis. Nephrol Dial Transplant 1991; 6: (suppl. 3) 83-5.
12. Haeffner-Cavaillon N, Kazatchkine MD. Methods for assessing monocytic cytokine production as an index of biocompatibility. Nephrol Dial Transplant 1994; 9: (suppl. 2) 112-5.
13. Raetz CRH. Biochemistry of endotoxins. Annu Rev Biochem 1990; 59: 129-70.
14. Levin J, Tomasulo PA, Olser RS. Detection of endotoxin in human blood and demonstration of an inhibitor. J Lab Clin Med 1970; 75: 903-11.
15. Obayashi T. Addition of perchloric acid to blood samples for colorimetric limulus test using chromogenic substrate: comparison with conventional procedures and clinical applications. J Lab Clin Med 1984; 104: 321-30.
16. Roth RI, Levin FC, Levin J. Optimization of detection of bacterial endotoxin in plasma with the Limulus test. J Lab Clin Med 1990; 116: 153-61.
17. Lemke H. Methods for the detection of endotoxins present during extracorporeal circulation. Nephrol Dial Transplant 1994; 9: (suppl. 2) 90-5.
18. Seydel U, Brandenburg K. Conformations of endotoxin and their relationship to biological activity. In: Nowotny A, Spitzer JJ, Ziegler EJ, eds. Cellular and molecular aspects of endotoxin reactions. Amsterdam: Elsevier Science Publishers B.V., 1990; 61-71.
19. Ronco C, Cappelli G, Ballestri M, et al. On line filtration of dialysate: structural and functional features of an asymmetric polysulfone hollow fiber ultrafilter (Diaclean). Int J Artif Organs 1994; 17: 515-20.
20. Kastowsky M. Modelling the three-dimensional structure of lipopolysaccharide. In: Levin J, Alving CR, Munford RS, Stütz PL, eds. Bacterial endotoxin: recognition and effector mechanisms. Amsterdam: Elsevier Science Publishers B.V., 1993; 61-70.
21. Bernick JJ, Port FK, Favero MS, Brown DG. Bacterial and endotoxin permeability of hemodialysis membranes. Kidney Int 1979; 16: 491-6.
22. Bernick JJ, Port FK, Favero MS. In vivo studies of dialysate-related endotoxemia and bacteremia. Nephron 1981; 27: 307-12.
23. Port FK, Bernick JJ. Pyrogen and endotoxin reactions during hemodialysis. Contrib Nephrol 1983; 36: 100-6.
24. Klinkmann H, Falkenhagen D, Smollich BP. Investigation of the permeability of highly permeable polysulfone membranes for pyrogens. Contrib Nephrol 1985; 46: 174-83.
25. Bommer J, Becker KP, Urbaschek R, Ritz E, Urbaschek B. No evidence for endotoxin transfer across high flux polysulfone membranes. Clin Nephrol 1987; 6: 278-82.
26. Frinak S, Polarschegg HD, Levin NW, Pohlod DJ, Dumler F, Saravolatz LD. Filtration of dialysate using an on-line dialysate filter. Int J Artif Organs 1991; 14: 691-7.
27. Laude-Sharp M, Caroff M, Simard L, Pusineri C, Kazatchkine MD, Haeffner-Cavaillon N. Induction of IL-1 during hemodialysis: transmembrane passage of intact endotoxins (LPS). Kidney Int 1990; 38: 1089-94.
28. Urena P, Herbelin A, Zingraff J, et al. Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in vitro haemodialysis. Nephrol Dial Transplant 1992; 7: 16-28.
29. Laude-Sharp M, Haeffner-Cavaillon N, Caroff M, Lantreibecq F, Pusineri C, Kazatchkine MD. Dissociation between the interleukin-1-inducing capacity and limulus reactivity of lipopolysaccharides from gram-negative bacteria. Cytokine 1990; 2: 253-8.
30. Lonnemann G, Bingel M, Floege J, Koch KM, Shaldon S, Dinarello CA. Detection of endotoxin-like interleukin-1 -inducing activity during in vitro dialysis. Kidney Int 1988; 33: 29-35.
31. Lonnemann G, Schindler R, Lufft V, Mahiout A, Shaldon S, Koch KM. The role of plasma coating on permeation of cytokine-inducing substances through dialyser membranes. Nephrol Dial Transplant 1995; 10: 207-11.
32. Henderson LW, Koch KM, Dinarello CA, Shaldon S. Hemodialysis hypotension: the interleukin hypothesis. Blood Purif 1983; 1: 3-8.
33. Blumenstein M, Ziegler-Heitbrock HWL, Schiller B, Schmidt B, Ward RA, Gurland HJ. Differential activation of monocytes in haemodialysis patients exposed to different types of membranes. Scand J Immunol 1990; 31: 183-90.
34. Lonnemann G, Haubitz M, Schindler R. Hemodialysis-associated induction of cytokines. Blood Purif 1990; 8: 214-22.
35. Descamps-Latscha B, Herbelin A. Long-term dialysis and cellular immunity: a critical survey. Kidney Int 1993; 43: S135-42.
36. Lonnemann G. Dialysate bacteriological quality and the permeability of dialyzer membranes to pyrogens. Kidney Int 1993; 43: S195-200.
37. Otterlei M, Sundan A, Skjak-Braek G, Ryan L, Smidsrod O, Espevik T. Similar mechanisms of action of defined polysaccharides and lipopolysaccharides: characterization of binding and tumor necrosis factor alpha induction. Infect Immun 1993; 61: 1917-25.
38. Arduino MJ, Bland LA, McAllister SK, Favero MS. The effects of endotoxin-contaminated dialysate and polysuifone or cellulosic membranes on the release of TNFα during simulated dialysis. Artif Organs 1995; 19: 880-6.
39. Evans RC, Holmes CJ. In vitro study of the transfer of cytokine-inducing substances across selected high-flux hemodialysis membranes. Blood Purif 1991; 9: 92-101.
40. Lonnemann G, Behme TC, Lenzner B, et al. Permeability of dialyzer membranes to TNFα-inducing substances derived from water bacteria. Kidney Int 1992; 42: 61-8.
41. Man NK, Ciancioni C, Faivre JM, et al. Dialysis-associated adverse reactions with high-flux membranes and microbial contamination of liquid bicarbonate concentrate. Contrib Nephrol 1988; 62: 24-34.
42. Haeffner-Cavaillon, Jahns G, Poignet JL, Kazatchkine MD. Induction of interleukin-1 during hemodialysis. Kidney Int 1993; 43: S139-43.
43. Dinarelto CA, Lonnemann G, Maxwell R, Shaldon S. Ultrafiltration to reject human interleukin-1-inducing substances derived from bacterial cultures. J Clin Microbiol 1987; 25: 1233-8.
44. Tesh VL, Morrison DC. The physical-chemical characterization and biologic activity of serum released lipopolysaccharides. J Immunol 1988; 141: 3523-31.
45. Takayama K, Din ZZ, Mukerjee P, Cooke PH, Kirkland TN. Physicochemical properties of the lipopolysaccharide unit that activates B lymphocytes. J Biol Chem 1990; 205: 14023-9.
46. Seydel U, Labischinski H, Kastowsky M, Brandenburg K. Phase behavior, supramolecular structure, and molecular conformation of lipopolysaccharide. Immunobiol 1993; 187: 191-211.
47. Takayama K, Mitchell DH, Din ZZ, Mukerjee P, Li C, Coleman DL. Monomeric Re lipopolysaccharide from Escherichia coli is more active than the aggregated form in the Limulus amebocyte lysate assay and in inducing Egr-1 mRNA in murine peritoneal macrophages. J Biol Chem 1994; 269: 2241-4.
48. Pearson FC. Endotoxin. In: Robinson JR, ed. Pyrogens. Endotoxins, LAL testing, and depyrogenation. Advances in parenteral sciences. New York: Marcel Dekker, 1985; 23-56.
49. Elm RJ, Wolff SM. Non-specificity of the Limulus amoebocyte lysate test: positive reactions with polynucleotides and proteins. J Infect Dis 1973; 128: 349-52.
50. Stumacher RJ, Kovnat MJ, McCabe WR. Limitations of the usefulness of the Limulus assay for endotoxin. N Engl J Med 1973; 288: 1261-4.
51. Taniguchi T, Katsushima S, Lee K, et al. Endotoxemia in patients on hemodialysis. Nephron 1990; 56: 44-9.
52. Nisbeth U, Hällgren R, Eriksson Ö. Danielson BG. Endotoxemia in chronic renal failure. Nephron 1987; 45: 93-7.
53. Mayer G, Watzke H, Schwarz HP, Stanek G, Graf H. Endotoxinaemia and bacterial contamination of dialysate in patients on chronic intermittent haemodialysis. J Nephrol 1989; 3: 173-6.
54. Mege JL, Sanguedolce MV, Purgus R, Moulin B, Bongrand P, Capo C, Olmer M. Chronic and intradialytic effects of highflux hemodialysis on tumor necrosis factor-α production: relationship to endotoxins. Am J Kidney Dis 1992; 20: 482-8.
55. Gordon SM, Tipple M, Bland LA, Jarvis WR. Pyrogenic reactions associated with the reuse of disposable hollow-fiber hemodialyzers. JAMA 1988; 260: 2077-81.
56. Vanholder R, Van Haecke E, Veys N, Ringoir S. Endotoxin transfer through dialysis membranes: small- versus large-pore membranes. Nephrol Dial Transplant 1992; 7: 333-9.
57. Van Haecke E, Vanholder R, Ringoir S. Absence of in vivo endotoxin transfer from dialysate to blood through large pore dialyzers (abstract). Kidney Int 1990; 37: 322.
58. Gazenfield-Gazit EE, Eliahou HE. Endotoxin antibodies in patients on maintenance hemodialysis. Isreal J Med Sci 1969; 5: 1032-6.
59. Yamagami S, Adachi T, Sugimura T, et al. Detection of endotoxin antibody in long-term dialysis patients. Int J Artif Organs 1990; 13: 205-10.
60. Mege JL, Brunet P, Capo C, Dussol B, Bongrand P, Berland Y. Non-endotoxinic tumour necrosis factor-α-inducing factors in haemodialysis. Nephrol Dial Transplant 1994; 9: 1606-10.
61. Lonnemann G, Schildler R. Ultrafiltration using the polysulfone membrane to reduce the cytokine-inducing activity of contaminated dialysate. Clin Nephrol 1994; 42: S37-43.
62. Gordon SM, Oettinger CW, Bland LA, et al. Pyrogenic reactions in patients receiving conventional, high-efficiency, or high-flux hemodialysis treatments with bicarbonate dialysate containing high concentrations of bacteria and endotoxin. J Am Soc Nephrol 1992; 2: 1436-44.
63. Schindler R, Dinarello CA. A method for removing interleukin-1 and tumor necrosis factor inducing substances from bacterial cultures by ultrafiltration with polysulfone. J Immun Meth 1989; 116: 159-65.
64. Cappelli G, Tetta C, Cornia F, et al. Removal of limulus reactivity and cytokine-inducing capacity from bicarbonate dialysis fluids by ultrafiltration. Nephrol Dial Transplant 1993; 8: 1133-9.
65. Di Felice A, Cappelli G, Facchini F, et al. Ultrafiltration and endotoxin removal from dialysis fluids. Kidney Int 1993; 43: S201-4.
66. Pereira BJG, Snodgrass BR, Hogan PJ, King AJ. Diffusive and convective transfer of cytokine-inducing bacterial products across hemodialysis membranes. Kidney Int 1995; 47: 603-10.
67. Bambauer R, Walther J, Meyer S, et al. Bacteria- and endotoxin-free dialysis fluid for use in chronic hemodialysis. Artif Organs 1994; 18: 188-92.
68. Schindler R, Lonnemann G, Schäffer J, Shaldon S, Koch KM, Krautzig S. The effect of ultrafiltered dialysate on the cellular content of interleukin-1 receptor antagonist in patients on chronic hemodialysis. Nephron 1994; 68: 229-33.
69. Krautzig S, Lonnemann G, Schindler R, Schäffer J, Shaldon S, Koch KM. Effect of ultrafiltered dialysate on the induction of IL-1 receptor antagonist (IL-1 RA) in ESRD patients on polysulfone-HD (abstract). Nephrol Dial Transplant 1995; 10: 1015.
70. Pegues DA, Oettinger CW, Bland LA, et al. A prospective study of pyrogenic reactions in hemodialysis patients using bicarbonate dialysis fluids filtered to remove bacteria and endotoxin. J Am Soc Nephrol 1992; 3: 1002-7.